FR2366293A1 - Nouvelles lactones utiles dans la synthese du thromboxane b2 - Google Patents

Nouvelles lactones utiles dans la synthese du thromboxane b2

Info

Publication number
FR2366293A1
FR2366293A1 FR7735045A FR7735045A FR2366293A1 FR 2366293 A1 FR2366293 A1 FR 2366293A1 FR 7735045 A FR7735045 A FR 7735045A FR 7735045 A FR7735045 A FR 7735045A FR 2366293 A1 FR2366293 A1 FR 2366293A1
Authority
FR
France
Prior art keywords
thromboxane
synthesis
lactons
new useful
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7735045A
Other languages
English (en)
Other versions
FR2366293B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2366293A1 publication Critical patent/FR2366293A1/fr
Application granted granted Critical
Publication of FR2366293B1 publication Critical patent/FR2366293B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

L'invention concerne de nouvelles lactones utiles comme intermédiaires pour la synthèse du thromboxane B2 .
FR7735045A 1976-04-14 1977-11-22 Nouvelles lactones utiles dans la synthese du thromboxane b2 Granted FR2366293A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/676,893 US4048194A (en) 1976-04-14 1976-04-14 6α-Methoxy-4α-hydroxy-2β-hydroxymethyl-3.alpha.-tetrahydropyranacetic acid 4α γ-lactone ethers and acylates

Publications (2)

Publication Number Publication Date
FR2366293A1 true FR2366293A1 (fr) 1978-04-28
FR2366293B1 FR2366293B1 (fr) 1981-12-24

Family

ID=24716462

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7711304A Granted FR2435474A1 (fr) 1976-04-14 1977-04-14 Nouveaux composes utiles dans la synthese du thromboxane b2
FR7735045A Granted FR2366293A1 (fr) 1976-04-14 1977-11-22 Nouvelles lactones utiles dans la synthese du thromboxane b2

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7711304A Granted FR2435474A1 (fr) 1976-04-14 1977-04-14 Nouveaux composes utiles dans la synthese du thromboxane b2

Country Status (5)

Country Link
US (8) US4048194A (fr)
JP (1) JPS537664A (fr)
DE (1) DE2715921A1 (fr)
FR (2) FR2435474A1 (fr)
GB (2) GB1534991A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100176A (en) * 1976-04-14 1978-07-11 The Upjohn Company 4,5-Didehydro-6-hydroxy-2β-arylmethoxymethyl-4α-tetrahydropyranacetic acids
US4100178A (en) * 1976-04-14 1978-07-11 The Upjohn Company 4,5-Didehydro-6-methoxy-2-arylmethoxymethyl-4α-tetrahydropyranacetic acid alkyl esters
US4083854A (en) * 1976-04-14 1978-04-11 The Upjohn Company 4,5-Didehydro-6-oxo-2-aryl-methoxymethyl-3α-tetrahydropyranacetic acids
US4100177A (en) * 1976-04-14 1978-07-11 The Upjohn Company 4,5-Didehydro-6-hydroxy-2-arylmethoxymethyl-4α-tetrahydropyranacetic acid alkyl esters
US20060116207A1 (en) * 2004-11-29 2006-06-01 Barona Tribal Gaming Authority Electronic gaming system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997570A (en) * 1971-08-05 1976-12-14 Chevron Research Company Alkenyl halolactone esters
US3971826A (en) * 1972-07-13 1976-07-27 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
US4001286A (en) * 1974-01-07 1977-01-04 The Upjohn Company Phenyl-substituted prostaglandin-β-type anologs
GB1532551A (en) * 1975-01-16 1978-11-15 Chembro Holdings Pty Ltd Furo(3,4-6)furone derivatives and their preparation
US4052552A (en) * 1976-08-20 1977-10-04 The Upjohn Company Thromboxane b analogs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/76 *

Also Published As

Publication number Publication date
US4143053A (en) 1979-03-06
US4048194A (en) 1977-09-13
US4102899A (en) 1978-07-25
FR2435474B1 (fr) 1982-08-06
DE2715921A1 (de) 1977-10-27
FR2366293B1 (fr) 1981-12-24
US4085120A (en) 1978-04-18
FR2435474A1 (fr) 1980-04-04
GB1534991A (en) 1978-12-06
GB1534986A (en) 1978-12-06
US4097493A (en) 1978-06-27
JPS537664A (en) 1978-01-24
US4102900A (en) 1978-07-25
US4120872A (en) 1978-10-17
US4086247A (en) 1978-04-25

Similar Documents

Publication Publication Date Title
FR2421874A1 (fr) Carboxyalkylacylamino-acides utiles comme agents hypotenseurs
FR2383960A1 (fr) Intermediaire dans la synthese de l'acide 1-carba-2-penem-3-carboxylique
BE847851A (fr) Compositions pour inhiber l'absorption du cholesterol,
FR2294999A1 (fr) Procede de preparation d'amides par hydrolyse biologique
BE835292A (fr) Procede de preparation de greffe d'arteres pour transplantations heteroplastiques
DE3585079D1 (de) Synthese von molekularsieb-metallsilikaten mittels heteropolymetallate.
BE814027A (fr) Application de beta-amino-nitriles comme catalyseurs pour la preparation des polyurethannes
FR2281376A1 (fr) Synthese de l'hydroxymethylphosphonate de di-polyoxyethylene
PT64673B (fr) Procede pour la preparation de nouvelles perhaloalcoylamidines substituees utilisees comme stimulants cardiaques
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
FR2280631A1 (fr) 1-(bis-ethoxycarbonyl) - acetylamino-3-methyl-3-(bis-ethoxycarbonyl)-acetylaminomethyl-5-dimethyl-cyclohexane pour la preparation de polyurethanes
BE810959A (fr) Synthese asymetrique de chrysanthemates d'alkyle
FR2366293A1 (fr) Nouvelles lactones utiles dans la synthese du thromboxane b2
FR2329274A1 (fr) Nouveaux amides, utiles en tant qu'inhibiteurs de l'ovulation
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
BE813807A (fr) Pyridinecarboxamide-sulfonylurees utiles comme agents hypoglycemiants
FR2285939A1 (fr) Procede pour le laminage d'ebauches de metal
US4082776A (en) 6-Alkoxy-4α-hydroxy-2β-tetrahydropyranacetic acid γ-lactones
ES454767A1 (es) Un metodo para producir compuestos de prostaglandinas.
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
IE39916B1 (en) New d-homo-steroids
FR2375185A1 (fr) Nouveaux composes utiles dans la synthese du thromboxane
BE833008A (fr) Procede ameliore de synthese de piperidinesulfamylurees utiles comme agents hypoglycemiants
FR2371450A1 (fr) Nouveaux composes utiles comme intermediaires dans la synthese d'analogues de thromboxane b2
SE7706083L (sv) Bicykliska laktondiolderivat jemte sett for deras framstellning

Legal Events

Date Code Title Description
ST Notification of lapse